Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -38.56% is 22% above its 5-year average of -49.69%, around the middle of its 5-year range (-72.16%–-15.79%).
As of the fiscal period ended Tuesday, June 30, 2026. 4.10% above its 12-month average of -40.21%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -38.56%.
RETURN ON INVESTED CAPITAL (ROIC)
-38.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-40.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-47.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-49.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-40.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+4.10%
CURRENT VS 3Y AVG
+18.26%
CURRENT VS 5Y AVG
+22.39%
CURRENT VS 10Y AVG
+5.07%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.87%
median of 701 covered companies
CURRENT VS SECTOR MEDIAN
-13.85%
vs the sector median at left
Minerva Neurosciences, Inc.
Market Cap
$158.63M
Return on Invested Capital (ROIC)
-38.56%
TTM Avg
-40.21%
3Y Avg
-47.17%
5Y Avg
-49.69%
Market Cap
$158.30M
Return on Invested Capital (ROIC)
-13.94%
TTM Avg
-16.11%
3Y Avg
-25.11%
5Y Avg
-17.04%
Market Cap
$155.86M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-138.87%
3Y Avg
-97.17%
5Y Avg
-81.85%
Market Cap
$155.42M
Return on Invested Capital (ROIC)
-56.53%
TTM Avg
-185.89%
3Y Avg
-125.01%
5Y Avg
-88.85%
Market Cap
$162.20M
Return on Invested Capital (ROIC)
-57.59%
TTM Avg
-65.44%
3Y Avg
-58.20%
5Y Avg
-45.38%
Market Cap
$164.54M
Return on Invested Capital (ROIC)
-135.38%
TTM Avg
-110.80%
3Y Avg
-91.23%
5Y Avg
-65.73%
Market Cap
$152.17M
Return on Invested Capital (ROIC)
-165.56%
TTM Avg
-176.54%
3Y Avg
-127.81%
5Y Avg
-112.12%
Market Cap
$151.98M
Return on Invested Capital (ROIC)
-27.25%
TTM Avg
-49.08%
3Y Avg
-43.31%
5Y Avg
-52.54%
Market Cap
$165.58M
Return on Invested Capital (ROIC)
-49.08%
TTM Avg
-23.18%
3Y Avg
-21.02%
5Y Avg
-18.22%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | $158.63M | -38.56% | -40.21% | -47.17% | -49.69% |
| Inogen, Inc. (INGN)vs › | $158.30M | -13.94% | -16.11% | -25.11% | -17.04% |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $155.86M | N/A | -138.87% | -97.17% | -81.85% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $155.42M | -56.53% | -185.89% | -125.01% | -88.85% |
| PepGen Inc. (PEPG)vs › | $162.20M | -57.59% | -65.44% | -58.20% | -45.38% |
| Coherus Oncology, Inc. (CHRS)vs › | $164.54M | -135.38% | -110.80% | -91.23% | -65.73% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.17M | -165.56% | -176.54% | -127.81% | -112.12% |
| Anavex Life Sciences Corp. (AVXL)vs › | $151.98M | -27.25% | -49.08% | -43.31% | -52.54% |
| Quanterix Corporation (QTRX)vs › | $165.58M | -49.08% | -23.18% | -21.02% | -18.22% |
| Codexis, Inc. (CDXS)vs › | $151.10M | -23.41% | -38.99% | -40.72% | -30.95% |
ROIC
-38.6%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -38.56% |
| 2026-03-31 | -31.13% |
| 2025-12-31 | -15.79% |
| 2025-09-30 | -57.61% |
| 2025-06-30 | -57.96% |
| 2025-03-31 | -61.81% |
| 2024-12-31 | -63.69% |
| 2024-09-30 | -63.92% |
| 2024-06-30 | -62.28% |
| 2024-03-31 | -51.29% |
| 2023-12-31 | -43.17% |
| 2023-09-30 | -35.16% |
| 2023-06-30 | -30.88% |
| 2023-03-31 | -46.02% |
| 2022-12-31 | -46.98% |
| 2022-09-30 | -72.16% |
| 2022-06-30 | -71.24% |
| 2022-03-31 | -68.05% |
| 2021-12-31 | -61.05% |
| 2021-09-30 | -33.12% |
| 2021-06-30 | -31.58% |
| 2021-03-31 | 6.09% |
| 2020-12-31 | 3.39% |
| 2020-09-30 | -7.06% |
| 2020-06-30 | -17.72% |
| 2020-03-31 | -85.66% |
| 2019-12-31 | -80.24% |
| 2019-09-30 | -55.83% |
| 2019-06-30 | -48.64% |
| 2019-03-31 | -44.81% |
| 2018-12-31 | -38.17% |
| 2018-09-30 | -32.48% |
| 2018-06-30 | -29.63% |
| 2018-03-31 | -25.66% |
| 2017-12-31 | -22.77% |
| 2017-09-30 | -21.52% |
| 2017-06-30 | -31.99% |
| 2017-03-31 | -25.86% |
| 2016-12-31 | -23.57% |
| 2016-09-30 | -21.37% |
| 2016-06-30 | -18.47% |
| 2016-03-31 | -31.06% |
| 2015-12-31 | -33.18% |
| 2015-09-30 | -29.37% |
| 2015-06-30 | -51.10% |
| 2015-03-31 | -59.57% |
| 2014-12-31 | -84.49% |
| 2014-09-30 | -70.52% |
| 2014-06-30 | -49.24% |
| 2014-03-31 | -11.37% |
| 2013-12-31 | -11.41% |
